Efficacy and Safety of First‐Line Treatment Options for Oncogene Wild‐Type Lung Adenocarcinoma With Liver Metastases
Liver metastasis represents one of the frequent drivers for cancer‐related mortality in lung adenocarcinoma. For advanced lung adenocarcinoma harboring wild‐type oncogene drivers, chemotherapies in combination with immune checkpoint inhibitors (ICIs) and/or bevacizumab (named IC, BC, and IBC, respectively) are alternat...